Anti‐tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards

Anti‐tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards

Saved in:

Bibliographic Details
Main Authors:	Ling Tang, Yuanyuan Song, Hong Zhang, Ruimin Hao, Xin Tong, Xing Ai, Jun Ma, Zhimin Yang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Cancer Communications
Online Access:	https://doi.org/10.1002/cac2.12630
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mapping the Global Research on Drug–Drug Interactions: A Multidecadal Evolution Through AI-Driven Terminology Standardization
by: Andrei-Flavius Radu, et al.
Published: (2025-07-01)

Research progress of novel anti-tumor drug formulations
by: Yan Liu, et al.
Published: (2024-12-01)

A bibliometric analysis of extracellular vesicles as drug delivery vehicles in disease treatment (2010–2024)
by: Wuli Guo, et al.
Published: (2024-12-01)

Mathematical Modeling of Cancerous Tumor Evolution Incorporating Drug Resistance
by: Francis Oketch Ochieng
Published: (2025-02-01)

Research Progress of Anti-lung Cancer Drug-related Interstitial Lung Disease
by: Zhimin XIAO, et al.
Published: (2025-04-01)

Reform and Development of Rare Diseases Drug Evaluation and Approval in China
by: HUANG Guo, et al.
Published: (2024-10-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights
by: Bingjun Bai, et al.
Published: (2024-12-01)

Original drugs approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2024
by: D. V. Kurkin, et al.
Published: (2025-07-01)

Evaluation of the efficacy of standard basic anti-inflammatory drugs and the time to start basictherapy for rheumatoid arthritis
by: Irina Mikhailovna Marusenko
Published: (2010-12-01)

Standardization Study of Antifertility Drug - Pippalyadiyoga
by: D. Shaila, et al.
Published: (2005-01-01)

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies
by: Yuqi Wang, et al.
Published: (2023-12-01)

Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers
by: Bocui Song, et al.
Published: (2025-04-01)

THE PROSPECTS OF THE USING OF THE REGISTER OF THE STANDARD LABELS OF THE INTERCHANGEABLE MEDICINES TO IMPROVE OF DRUG SUPPLY OF PEDIATRIC PATIENTS
by: G. Ia. Ibragimova, et al.
Published: (2019-01-01)

Brain-targeting Nanoparticle Drug Delivery Systems for Brain Tumors
by: Yi Zhao, et al.
Published: (2025-01-01)

Evolution of Drug Supply for Psoriasis from 2010 to 2022 &ndash; Real-World Claims Data Analysis in Germany
by: Hagenström K, et al.
Published: (2025-06-01)

Atrial arrhythmias associated with anti-tumor drugs in patients with malignant tumors and type 2 diabetes mellitus
by: Beibei Zhang, et al.
Published: (2025-05-01)

Improving drug–target affinity prediction by adaptive self-supervised learning
by: Qing Ye, et al.
Published: (2025-01-01)

Prospects for Expanding Drug Therapy for Multiple Drug Resistant and Extensively Drug Resistant Tuberculosis
by: G. N. Mozhokina, et al.
Published: (2022-04-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01)

Key Points for Quality Management in Phase Ⅰ Clinical Trials of Anti-Tumor Drugs
by: Li GONG, et al.
Published: (2025-05-01)

Applied of bioinformatics in drug discovery and drug development: Bioinformatic analysis 1996-2024
by: Irham Lalu Muhammad, et al.
Published: (2024-01-01)

Research on the quality supervision strategy of drugs sold on the internet under the MAH system
by: Zongliang Wen, et al.
Published: (2025-04-01)

Coregulation Supervision Strategy of Drug Enterprises under the Government Reward and Punishment Mechanism
by: Siyi Zhang, et al.
Published: (2021-01-01)

DrugBERT: a BERT-based approach integrating LDA topic embedding and efficacy-aware mechanism for predicting anti-tumor drug efficacy
by: Weiwei Zhu, et al.
Published: (2025-08-01)

Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
by: Maryam Saif Al Ali, et al.
Published: (2020-10-01)

The Epidemiology of Nonsteroidal Anti-Inflammatory Drugs
by: Jerry Tenenbaum
Published: (1999-01-01)

Ocular toxicity of Anti-Tubercular drugs
by: Ritika Aggarwal, et al.
Published: (2021-04-01)

Nephrotoxic characteristics of anti-tuberculosis drugs
by: G. N. Mozhokina, et al.
Published: (2019-11-01)

REFERENCE STANDARDS OF ACTIVE INGREDIENTS OF POTENT ANALGESIC DRUGS
by: A. V. Sosnov, et al.
Published: (2019-01-01)

Adverse Effects of Nonsteroidal Anti-inflammatory Drugs in Pediatrics: Case Series According to the Doctor Reports in Republic of Crimea through 2010 to 2018
by: Alexandr V. Matveev, et al.
Published: (2019-09-01)

SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles
by: Ting Zhang, et al.
Published: (2025-01-01)

SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles.
by: Ting Zhang, et al.
Published: (2025-01-01)

Bibliometric analysis of research trends and prospective directions of Akkermansia muciniphila from 2010 to 2024
by: Yanan Wang, et al.
Published: (2025-04-01)

Emerging trends of the tumor microenvironment in peritoneal malignancies (2010-2024): a visualization analysis
by: Hua Duan, et al.
Published: (2025-06-01)

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects
by: Han Han, et al.
Published: (2025-07-01)

Prosecutorial supervision of covert investigative (search) actions during the investigation of drug-related crimes
by: I. Yu. Shelikhovska
Published: (2025-04-01)

Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance
by: Sam Song, et al.
Published: (2016-01-01)

Drug–drug interactions in neonatal intensive care: A prospective cohort study
by: Haline Tereza Costa, et al.
Published: (2021-03-01)